Different types of printing methods have attracted interest as emerging technologies for fabrication of drug delivery systems (DDS). Recent examples include the use of diverse types of inkjet (IJ) printers for depositing drug-loaded inks to produce accurately and precisely dosed units of active pharmaceutical ingredients (APIs The concepts include on the simplest level accurately deposited doses of drug substances and one-layer films. On the other hand, printing technologies allow the manufacture of advanced multi-layer membranes, various type of stacked systems, and integrated multi-compartment systems with bioactive components. This talk will present examples on the use of printing technologies that are of potential interest in printing technologies in personalization of drug products.
About Niklas Sandler
Niklas Sandler received his M.Sc. (Pharm.) in 1998 and Ph.D. in pharmaceutical technology in 2003 from the University of Helsinki. 2005-2006 he was a postdoctoral researcher at the University of Otago, NZ. Senior scientist at AstraZeneca, R&D UK 2006-2008. Since 2009 professor in Pharmaceutics at Åbo Akademi University (ÅAU), Turku, Finland and heads the research group in drug-delivery and pharmaceutical technology. He has pioneered in research around printable drug-delivery systems.
About Åbo Akademi University
Åbo Akademi University is an internationally acknowledged research university, the only Swedish-language multidisciplinary university in Finland. Although most degree programmes are offered in Swedish a number of English-taught programmes are available at the master and doctoral level. ÅAU has an acknowledged position at the forefront of research in areas such as biosciences, computer science, democracy, human rights, material sciences, process chemistry and psychology. ÅAU provides a unique environment for research and education in the historical campus areas of Åbo (Turku in Finnish) and Vasa (Vaasa).